NCT07646678 A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia Status RECRUITING Phase PHASE2/PHASE3
NCT07625280 A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH Status RECRUITING Phase PHASE3
NCT07500090 A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH) Status RECRUITING Phase PHASE3
NCT06843590 A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia Status RECRUITING Phase PHASE2
NCT06767683 A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia Status RECRUITING Phase PHASE2/PHASE3
NCT06752668 A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia Status RECRUITING Phase PHASE2
NCT06525077 Safety and Efficacy of FT218 in Idiopathic Hypersomnia (REVITALYZ) Status COMPLETED Phase PHASE3
NCT06484348 Deciphering the Interactions Between Food Intake, Sleepiness, and Nighttime Sleep Quality in Patients With Type 1 Narcolepsy and Idiopathic Hypersomnia Status RECRUITING Phase NA
NCT06252571 a Chronobiological Treatment Combining Evening Melatonin and Morning Light Therapy in Idiopathic Hypersomnia: a Prospective, Double Bind, Randomized, Placebo-controlled -Trial Status RECRUITING Phase PHASE2
NCT05837091 Low Sodium Oxybate in Patients With Idiopathic Hypersomnia Status RECRUITING Phase PHASE4
NCT05615584 Spectrometry (MRM) Versus I 125 Radioimmunoassay (RIA) for Quantification of Orexin-A of Patients With Hypersomnolence Status COMPLETED Phase NA
NCT05371483 Cardiovascular and Cognitive Implications of Central Disorders of Hypersomnolence and Their Treatments Status ENROLLING_BY_INVITATION Phase N/A